Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Engage Grants Program

Université Laval

$25,000.00

Development of a technology to monitor viability and stability of probiotics compounds

FY 2014-15

Summary
Pfizer inc., a major biopharmaceutical company operating worldwide, receives at its production site probioticscells which are used to form an encapsulated product. These cells represent a scientific challenge in terms oflife expectancy with respect to storage time (""shelf life"") which depends on several factors such as lyophilizedpowder manufacturing critical process parameters. A major challenge for Pfizer inc. is to predict theencapsulated product activity (bacteria viability) based on these factors. The objective of this project is todevelop analytical methods to predict the viability of probiotic cultures depending on critical processconditions. The main outcome of this project will be a model capable of predicting the viability of probioticbatches. Finally, this project will improve the Pfizer inc. probiotic production process of the commercializedproduct.
Program
Engage Grants Program
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
462671-2014
Name nom
Gaillet, Bruno
Department département
Génie chimique
Organization id
51
Institution établissement
Université Laval
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2014
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1552
Committee name en
Quebec Internal Decision Committee
Committee name fr
Comité de décision interne pour le Québec
Area of application code
500
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Manufacturing processes and products
Area of application fr
Procédés et produits industriels
Research subject code
1802
Research subject group en
Chemical engineering
Research subject group fr
Génie chimique
Research subject en
Biochemical engineering
Research subject fr
Génie biochimique
Partie
1
Nb partie
1
Application title
Development of a technology to monitor viability and stability of probiotics compounds
Keyword
NSERC
Application summary
Pfizer inc., a major biopharmaceutical company operating worldwide, receives at its production site probioticscells which are used to form an encapsulated product. These cells represent a scientific challenge in terms oflife expectancy with respect to storage time (""shelf life"") which depends on several factors such as lyophilizedpowder manufacturing critical process parameters. A major challenge for Pfizer inc. is to predict theencapsulated product activity (bacteria viability) based on these factors. The objective of this project is todevelop analytical methods to predict the viability of probiotic cultures depending on critical processconditions. The main outcome of this project will be a model capable of predicting the viability of probioticbatches. Finally, this project will improve the Pfizer inc. probiotic production process of the commercializedproduct.